AI to diagnose invisible brain abnormalities in children with epilepsy
Posted:
MELD Graph is an AI tool that could drastically change the care of 30,000 patients in the UK and 4 million patients worldwide who have focal cortical dysplasia (FCD) – a leading cause of epilepsy.
The study, published in JAMA Neurology, shows how the tool significantly improves the detection of FCD. And researchers believe that it will speed up diagnosis times, get patients the surgical treatment they need quicker, and reduce costs to the NHS by up to £55,000 per patient.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…